Brexpiprazole: A New Treatment Option for Schizophrenia

News
1

Summary:

This article reviews brexpiprazole, a medication recently approved to treat patients with schizophrenia. Brexpiprazole was well-tolerated, and adverse reactions were statistically insignificant.

They included nausea; insomnia; headache; agitation; akathisia; and weight gain or changes in lipid, creatine phosphokinase, glucose, or prolactin levels.

Brexpiprazole is taken once daily without regard to food, and the dose should be adjusted in patients who receive moderate or strong CYP450 inhibitors or inducers and in patients with hepatic or renal disease.

Source:

More information:

1 Like
2

Still not available in Europe nearly a year later.

3

not in new zealand either, it sucks that drugs are not released world wide

2 Likes
4

Yea like bitoperin for example in Korea and Japan. Why is that not in the US?

5

I think that there would be a organization that regulate drugs and release them worldwide.

Anyway, brexpiprazole is more potent than aripiprazole and maybe it’s good for those who have compulsive behavior because of aripiprazole.

6

I’m on 4mg of it

3mg didn’t cut it

I can’t really say if it works because it needs a couple of weeks to get in my body before I toss it or keep it or do anything…I’m taking time off to get adjusted and get healthy.

2mg worked alright for a while, then it went sideways

4 Likes